Konidaris Tasos Insider Trades

Insider Trading History

Track insider trading activity for Konidaris Tasos. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President & CFO
Holding Value $6.37M 471,469 shares
Last Trade
Mar 04, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$585k 43,982 shares
$13.30
$13.52
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President & CFO
Holding Value $6.08M 449,434 shares
Last Trade
Mar 04, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$293k 22,035 shares
$13.30
$13.52
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President & CFO
Holding Value $1.19M 87,963 shares
Last Trade
Mar 04, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$665k 49,982 shares
$13.30
$13.52
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President & CFO
Holding Value $5.78M 427,487 shares
Last Trade
Mar 03, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.79M 284,548 shares
$13.31
$13.52
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President & CFO
Holding Value $8.89M 657,304 shares
Last Trade
Mar 03, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.85M 589,883 shares
$13.31
$13.52
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President & CFO
Holding Value $1.16M 85,617 shares
Last Trade
Mar 03, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.85M 589,883 shares
$13.31
$13.52
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President & CFO
Holding Value $982k 72,622 shares
Last Trade
Mar 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2M 145,244 shares
$13.77
$13.52
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President & CFO
Holding Value $1.65M 122,152 shares
Last Trade
Aug 15, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.07M 219,159 shares
$9.43
$13.52
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President & CFO
Holding Value $4.61M 341,311 shares
Last Trade
Aug 14, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.11M 119,206 shares
$9.30
$13.52
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President & CFO
Holding Value $6.23M 460,517 shares
Last Trade
Aug 13, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.49M 161,365 shares
$9.22
$13.52
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President & CFO
Holding Value $8.41M 621,882 shares
Last Trade
Mar 05, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$891k 100,000 shares
$8.91
$13.52
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President & CFO
Holding Value $9.76M 721,882 shares
Last Trade
Mar 04, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$199k 22,497 shares
$8.84
$13.52
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President & CFO
Holding Value $10.1M 744,379 shares
Last Trade
Mar 04, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$389k 43,981 shares
$8.84
$13.52
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President & CFO
Holding Value $1.78M 131,945 shares
Last Trade
Mar 04, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$389k 43,981 shares
$8.84
$13.52
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President & CFO
Holding Value $9.47M 700,398 shares
Last Trade
Mar 03, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.17M 133,410 shares
$8.76
$13.52
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President & CFO
Holding Value $0 0 shares
Last Trade
Mar 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$314k 36,197 shares
$8.67
$13.52
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President & CFO
Holding Value $7.62M 563,513 shares
Last Trade
Mar 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$314k 36,197 shares
$8.67
$13.52
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President & CFO
Holding Value $7.44M 550,019 shares
Last Trade
Mar 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$117k 13,494 shares
$8.67
$13.52
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President & CFO
Holding Value $7.55M 558,106 shares
Last Trade
Mar 12, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$466k 87,720 shares
$5.31
$13.52
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President & CFO
Holding Value $7.13M 527,316 shares
Last Trade
Mar 12, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$163k 30,790 shares
$5.31
$13.52

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up